indicates

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Walking the Tightrope

As we stand on the verge of a new era in crypto, it’s crucial to reaffirm the importance of decentralization. Beyond being a mere aspiration, decentralization serves as the lifeblood of the crypto world, standing as the pivotal force that draws the line between freedom and control. Amidst the hype surrounding the impending approval of a spot Bitcoin ETF in the United States, accompanied by the influx of capital from behemoths like BlackRock, the immediate market surge raises a serious question for the future of crypto. Are people here for

Kashifu Inuwa: Putting NITDA on the Cusp of a Revolution

Source: NITDA / National Information Technology Development Agency (NITDA), Federal Government of Nigeria The National Information Technology Development Agency (NITDA), the Federal Government Agency responsible for the development of the Information Technology sector in Nigeria. Written by Iklima Musa, Lagos, Nigeria 28/09/2022. LAGOS, NIGERIA, Sept 29, 2022 - (ACN Newswire) - Nothing offers a more reliable picture of a country's economic performance better than a periodic assessment of sectoral contribution to Gross Domestic Product (GDP). It's no less so in Nigeria where a report by the National Bureau of Statistics